CRTO 250516 45.00C(CRTO250516C45000) Stock Price Today

US OptionsDetailed Quotes

CRTO250516C45000

Watchlist

0.25
0.000.00%

15min DelayTrading Apr 2 11:48 ET

0.00High0.00Low

Intraday

5D
Daily

News

Criteo Is Maintained at Neutral by Susquehanna
Dow Jones12:36 ET · Ratings
CRITEO TO PRESENT AT THE J.P. MORGAN 53RD GLOBAL TECHNOLOGY, MEDIA AND COMMUNICATIONS CONFERENCE ON MAY 14, 2025
PR NewswireApr 30 07:00 ET
Benchmark Co. Maintains Criteo(CRTO.US) With Buy Rating, Cuts Target Price to $55
Moomoo NewsApr 29 03:33 ET · Ratings
Earnings Preview: Criteo to Report Financial Results Pre-market on May 02
Moomoo NewsApr 28 21:00 ET
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
MT NewswiresApr 28 11:23 ET
Citigroup warns: Tariff impacts North American Internet in Q1, lowering expectations and Target Price before earnings.
Citigroup recently released a Q1 outlook report for North America's Internet Industry stocks, adjusting the earnings expectations and Target Prices for most companies covered in the sector.
Zhitong FinanceApr 28 06:52 ET

Comments

Moomoo AI

Mar 17, 2024 20:58

Despite strong share performance, the market may not be judging the company on earnings growth due to decreased earnings per share. Revenue and earnings trends could have influenced share price. The gain surpassed the average annual return of 7% over five years, suggesting the company may be attracting new investors.

Optimism for Criteo (NASDAQ:CRTO) Has Grown This Past Week, Despite Five-year Decline in Earnings

Moomoo AI

Mar 2, 2024 07:41

Petrus Advisers views Criteo as an 'attractive investment opportunity' that could be strengthened by requested actions. Ocular Therapeutix's leadership changes are seen as a positive step towards becoming a leader in retina care. Starboard previously labeled Fortrea shares as 'undervalued' and an 'attractive investment opportunity'.

Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors -- Barrons.com

Moomoo AI

Feb 29, 2024 03:53

The CEO & Director's recent share selling, even at below current price, may indicate insiders see the shares as fully valued. Despite significant insider ownership, the long-term outlook lacks positivity.

Don't Ignore The Insider Selling In Criteo

Moomoo AI

Feb 23, 2024 00:25

Petrus Advisers urges Criteo for a strategic review and an investor day to explain the Retail Media strategy and a new mid-term plan, believing the current stock fluctuation is not rewarding.

Criteo Gains as Activist Pushes for Strategic Review, Board Refresh

Moomoo AI

Jan 5, 2024 20:33

The weak ROE concerns as it could contribute to declining net income. Analysts anticipate improved earnings growth but the absence of dividends, despite high profit retention, casts doubt on the company's growth strategies.

Does The Market Have A Low Tolerance For Criteo S.A.'s (NASDAQ:CRTO) Mixed Fundamentals?